Application

19634606 · 2-(4-(2-(7,8-DIMETHYL-[1,2,4]TRIAZOLO[1,5-A] PYRIDIN-6-YL)-3-ISOPROPYL-1H-INDOL-5-YL)PIPERIDIN-1-YL)ACETAMIDE SALT AND CRYSTALLINE FORMS THEREOF

Filed 2026-03-31 · Pending The official file ↗ · Art unit 1624 · Examiner Brian E McDowell Typical · CPC C07D 471/04 · Bristol-Myers Squibb Company · Blank Rome LLP (NY) - Beeline Medicines

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

1.8 mo

to disposition n/a

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.